Abstract:Ethnopharmacological relevance: Clerodendranthus spicatus is a traditional Chinese medicine and has been used to treat diabetes and some kidney diseases for a long history. Aim of the study: The research aimed to study the active constituents, the potential targets and the related mechanisms of C. spicatus in the treatment of diabetes through network pharmacology method and verify the antidiabetic activity by molecular biology experiments. Materials and methods: A comprehensive network pharmacology strategy was used to predict the key active constituents, the key targets and the related mechanisms and pathways of C. spicatus in the treatment of diabetes. The strategy mainly included screening and predicting potential active constituents and targets by network construction, GO (Gene Ontology) and KEGG (Kyoto Encyclopedia of Genes and Genomes) enrichment analysis. Based on the predicted results, C. spicatus was extracted by ultrasonic method with 50% ethanol and enriched by using macroporous resin. The compounds with potential antidiabetic effects were separated through silica-gel column chromatography and HPLC (high performance liquid chromatography), and then identified by MS (mass spectrum) and NMR (nuclear magnetic resonance). The C. spicatus extract and isolated compounds were tested by in-vitro and cell experiments to verify their antidiabetic activities, including antioxidant activities, inhibition activities on α-glucosidase and α-amylase, the influence on glucose uptake in cell experiments and the Western blot of PI3K and Akt expression levels. Results: A total of 18 active constituents and 16 key targets of C. spicatus in the treatment of diabetes were screened out through network pharmacology method. Phenolic acids might be the main target compounds for the next research. After extraction, enrichment and separation, the phenolic acids-enriched fraction of C. spicatus and four phenolic acid compounds (helisterculin C, salvianolic acid B, orthosiphoic acid E and ethyl caffeate) were obtained. Among them, salvianolic acid B was isolated from C. spicatus for the first time and orthosiphoic acid E was isolated from natural products for the first time. In experiment verification, the crude extract of C. spicatus, the phenolic acids-enriched fraction and the four compounds all showed antidiabetic potentials. The phenolic acids in C. spicatus had antioxidant activities, inhibitory activities on α-amylase and α-glucosidase and promoted glucose uptake in L6 cells through PI3K/Akt signaling pathway. Conclusions: This study showed that C. spicatus had antidiabetic activities with the mechanism of the mode of multi-compounds acting on multi-targets and multi-pathways. The main active phenolic acid compounds were also identified. It provided theoretical basis for further development and utilization of C. spicatus.

UHPLC–PDA–Q‐TOF–MS–α‐amylase–FLD activity detection system and molecular docking

Screening, Characterization of Trace Α-Glucosidase Inhibitors from the Root of Pueraria Lobata and Evaluation of Their Hypoglycemic Activity

Screening Inhibitors of α‐Amylase in Polygala Radix Based on an Online Targeted Detection System and Molecular Docking

Screening and identifying of α‐amylase inhibitors from medicine food homology plants: Insights from computational analysis and experimental studies

Investigation Of The Potential Antidiabetic Effect Of Zygophyllum Sp. By Studying The Interaction Of Its Chemical Compounds With Alpha-Amylase And Dpp-4 Enzymes Using A Molecular Docking Approach

Integration of Deep Learning and Sequential Metabolism to Rapidly Screen Dipeptidyl Peptidase (DPP)-IV Inhibitors from Gardenia jasminoides Ellis

Pancreatic lipase and alpha-glucosidase inhibitors screening from Schisandra chinensis based on spectrum-effect relationship and ultra-high-performance liquid chromatography-tandem mass spectrometry

Identification of Α-Glucosidase Inhibitors from Mulberry Using UF-UPLC-QTOF-MS/MS and Molecular Docking

Rapid screening and separation of active compounds against α-amylase from Toona sinensis by ligand fishing and high-speed counter-current chromatography

Studies on the key constituents and the related mechanisms of Clerodendranthus spicatus in the treatment of diabetes based on network pharmacology

Determination of Α-Glucosidase Inhibitors from ScutScutellaria Baicalensis Using Liquid Chromatography with Quadrupole Time of Flight Tandem Mass Spectrometry Coupled with Centrifugal Ultrafiltration

Identification of the effective α-amylase inhibitors from Dalbergia odorifera: Virtual screening, spectroscopy, molecular docking, and molecular dynamic simulation

Machine learning combined with molecular simulations to screen α-amylase inhibitors as compounds that regulate blood sugar

Screening for potential alpha-Glucosidase inhibitors in Coptis chinensis franch extract using ultrafiltration LC-ESI-MSn

Utilizing HPLC-DAD, Multivariate Analysis, Molecular Docking, and in Vitro Validation Methods to Investigate Phenolic Compounds with Potential Antidiabetic Properties in Fraxinus Mandshurica

Identification of α-Glucosidase Inhibitors from Scutellaria edelbergii: ESI-LC-MS and Computational Approach

Screening and Activity Analysis of α-Glucosidase Inhibitory Peptides Derived from Coix Seed Prolamins Using Bioinformatics and Molecular Docking

Rapid Screening and Identification of Α-Amylase Inhibitors from Garcinia Xanthochymus Using Enzyme-Immobilized Magnetic Nanoparticles Coupled with HPLC and MS.

SCREENING FOR Α-Glucosidase INHIBITORS FROM COPTIDIS-REHMANNIAE HERB COUPLE BY USING ULTRAFILTRATION LIQUID CHROMATOGRAPHY/MASS SPECTROMETRY

Systematic Analysis and Identification of the Absorption and Metabolic Components of Zengye Decoction in Type 2 Diabetic Rats by HPLC-ESI-Q-TOF–MS/MS

Enzyme immobilized on magnetic fluorescent bifunctional nanoparticles for α-glucosidase inhibitors virtual screening from Agrimonia pilosa Ledeb extracts accompanied with molecular modeling